沐舒坦不同霧化劑量在氣管切開(kāi)早期氣道管理中的實(shí)驗(yàn)研究-百度文.23485

?

?1,2:24(0.9%5ml/d1(2mg/kg5ml2(5mg/kg0.5ml,2L/min7dTNF2αILTNF2αIL,(<0.2(<0.5mg/(kg表殊,泌高狀態(tài)關(guān)鍵詞:;

;

;

;

;;

圖類

文獻(xiàn)標(biāo)識(shí):A

文章編號(hào)2010.09.ofdifferentofambroxolearlytracheotomyHXianghui,YangMeili,Zheng∥HospitalofXX361000,atdifferentonofairwayaftertracheo2tomy.ofrabbitmodeltothestudy.fourallocaintogroupsof,nebulizationwith5ml/d(controlgroup2mgkg21d21,5mg21(experimentalrespectivelytheflowratebeing2L/min4timesperday.Ontracheothe,2αandIL28inoutflowofbronchiallavage,mucosalinjuryweredetected.ResultsTheresultsof,ofTN2αandIL28,andtheproportionmucosalinjurysizeshowedsignificantdifferencesthe3group,groupCweresignificantlylowerofgroups(P<0.01for.Conclusionrecommendedofambroxolforairwaytracheotomyis5mgkg?canex2pressionhypersecretionofmucosa.Keywords:rabbittracheotomy;airwaymanagementnebulization;ambroxoldosefor;:1.(19792,::2010-01-08;:2010-02-04,[1]

,0.5~2.0mg/(kg?d,?d展[324],而增保得探討筆兔究模型觀察不同控染保組織際和安,1

1.1

24,2.5kg,7~8,[5],U/kg,(,5ml(24組、2組,組8,三組、和切開(kāi)情況比較,差異計(jì)學(xué)意義(P1.2

2.

霧化2.1

霧化式

研究表明當(dāng)氧流6L/min5ml能產(chǎn)生想化[6]霧6L/min氧流,流氧化流2L/min霧4霧化霧,20min霧化,?1學(xué)2010259化,5ml霧化2.

霧化

,、8:00、16:00化,1.

霧化

切開(kāi),照組化化,5ml/d;1組和22mg/kg5mg/kg化5ml化霧化

切開(kāi)7d開(kāi)1NXE,,,TN2αIL15~6mm700,J,2.3

SPSS11.x,,α=0.2

,;,.

x±sTNF2αIL28傷1.0.6895.081±751±10.

14.1.4301.396±493±1.02860.750±403

282.2703.199±9.F14.4847.66701:P<0.01;TNF2αIL28,2,P<0.P>0.3

,,[2],TNF2αIL28[10211],BALF血清[12],選BALTN2αIL檢腺,目國(guó)外祛藥常

[13],選兔給藥,能準(zhǔn)使果更服

1,1,說(shuō)2mg/(kg?能,P>,說(shuō),發(fā)藥能2?d,,Kupczyk[14215],,,mg/(kgd,[4]4

小前入選床療具很隨,缺乏礎(chǔ),影響治最,家兔?入,釋雙重?2?保,為臨床基臨:[1]

,.0.45%中[J].[2]RizoliSKapusA,Parodo,etimmu2nomodulationandaccompaniedbychangesinexpression[J].JSurgRes,1999,83(2:1302135.[3]

,,響[J].,2008,28(122224.[4]

,.[J].,2008,25(3:4212422.[5]

[M].:,1998:479.[6]

,.

[J].,2008(:605[7]

,,[J].31(7:3732375.[8]

.[J].,1996,12(5[9],2001:102321026.

[M].:,Angel,LunauMal.andairwayinfectionduring2chronicobstructivedisease[J].RespirCare,2001,163(2:3492355.[11]ThomasS.Tumour2alphamultifcytokineinCellBiol,2001,79(2:1322140.[12]MilloJLMJ,C,Compartmen2andinhibitorsin2tor[J].Intensive,2004,30(1Mand2disorders.I.Pathophysiology2[J].PolMerkur:2452247.[15]SeverinaIS,,PyatakovaV,al.Am2broxolasinhibitorofnitricoxideofsoluble[J].Eur,2000,:61264.

:2,(規(guī)定內(nèi)容,較為準(zhǔn)客觀地鍵詞;

;

;

;

中圖號(hào)

識(shí)碼:A

章:1001-4152(2010DOI:10.2010.09.ofaquantitativesystemcommunity′∥YuJianqin(CommunityServiceTradi2tionalMedicineHospitaly,277101,Abstractestablishanindexforevaluatingofreviewwasusedtoconstructfofevaluationsystememployedtoofexpertsoasconfirmlevellevel3indicators,